Technology

AI-enabled Site-Specific Integration Cell Line Development Platform

Home/Technology

Introduction

Great Bay Bio developed a proprietary AlfaCell platform that applies Site-Specific Integration (SSI) technology and AI-enabled cell selection to accurately insert the target genes into specific “hot spot” within the genome of a host cell line. AlfaCell platform significantly reduces the time, manpower, and cost associated with developing high-performance mammalian cell lines.

Why Choose AlfaCell Platform?

Time-saving & Labor-saving

1.5 months to complete RCB construction
Only one 96-well plate is needed

High-yield & Stable

High titer: 5 ~ 16 g/L
Stability: 100%

High-quality BsAb

Correct paring rate ＞ 80%

Process

Case Study

Strategic Partnership Models

    AlfaCell Service: RCB development in 1.5 months
    AlfaCell Out-licensing: CHO-K1 AlfaCell out-licensing
    AlfaCell Co-development: Customized site-specific cell line co-development
Message